Biotech · Private company
Shanghai Pharma Biotherapeutics USA Inc.
Track this companyFree. Adds Shanghai Pharma Biotherapeutics USA Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SPH3127Phase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- SPH4336Phase 2 · Liposarcoma, DedifferentiatedClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic LiposarcomasPHASE2 · TERMINATED · started Aug 31, 2023ClinicalTrials.gov NCT05580588 · fetched Nov 12, 2026
- Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative ColitisPHASE2 · TERMINATED · started Mar 21, 2022ClinicalTrials.gov NCT05019742 · fetched Nov 12, 2026